Posted by ABMN Staff on Mar 29th, 2024
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat Ratings reports....
More of this article »